Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Tesis doctoral (DoctoralThesis)

Células del neuroepitelio olfativo de pacientes para la búsqueda de un modelo in vitro e in vivo en trastornos psiquiátricos

  • Delgado Sequera, Alejandra Cristina
En las enfermedades mentales, la búsqueda de biomarcadores se ha visto frenada por la imposibilidad de obtener muestras neurales de pacientes vivos. El neuroepitelio olfativo (“Olfactory NEuroepithelium”, ONE) es un tejido nervioso periférico que representa un interesante modelo sustitutivo para estudiar los efectos de fármacos en el cerebro, así como la propia etiopatogenia de la enfermedad, ya que está estrechamente relacionado con el sistema nervioso central. En la presente tesis utilizamos células derivadas de ONE humano como herramienta para buscar factores de riesgo biológicos en los trastornos mentales, concretamente factores de riesgo potenciados por el consumo de cannabis y factores de riesgo y de respuesta al tratamiento farmacológico en el trastorno bipolar tipo I (bipolar disorder I, BDI). El cannabis es la tercera sustancia psicoactiva más consumida, pero también recibe una atención considerable como posible fármaco terapéutico. El BD es una enfermedad psiquiátrica altamente heredable, con una prevalencia a lo largo de la vida del 1-3%. El tratamiento de primera línea es el litio que consigue una respuesta satisfactoria en monoterapia de aproximadamente un 30%. La falta de comprensión neurobiológica de estas patologías impide la mejora de los actuales tratamientos y el descubrimiento de nuevas dianas terapéuticas. En esta tesis utilizamos células ONE de consumidores crónicos de cannabis y de sujetos control sanos para evaluar alteraciones en los procesos celulares relevantes, e identificar cambios en las vías proteómicas funcionales debido al consumo de cannabis. Siguiendo una estrategia similar, buscamos biomarcadores que puedan ayudar a predecir la respuesta clínica al litio en pacientes con BD que responden (lithium responder, LR) o no al litio (lithium non responder, LNR), y descubrir nuevas dianas terapéuticas. Además, estudiaremos el potencial de diferenciación neural de las células derivadas del neuroepitelio olfativo in vivo. Las células del ONE de consumidores de cannabis mostraron alteraciones en la expresión de proteínas relacionadas con el citoesqueleto, la proliferación y la muerte celular. Nuestros resultados indican que el cannabis puede alterar procesos clave del cerebro en desarrollo, algunos de los cuales son similares a los registrados en trastornos mentales como la esquizofrenia y el trastorno bipolar. Estudios posteriores demostraron que el cannabis provocaba un aumento del tamaño de las células y alteraciones morfológicas evidentes a través de la tinción de β-Tubulina III, así como una mayor expresión de β- actina y una disminución en la adhesión focal, sugiriendo anormalidades del citoesqueleto y del sistema de adhesión celular. Por otro lado, el análisis proteómico realizado tanto en las células derivadas de pacientes con BD como en muestras de sangre (Peripheral Blood Mononuclear Cell, PBMCs) extraídas de los pacientes mostró que la vía de señalización PKA estaba regulada a la baja en las células del ONE derivadas de pacientes LR en comparación con las de control sano, pero estaba regulada al alza en LNR. El tratamiento in vitro con litio restauró la vía PKA, pero exclusivamente en pacientes LR. Una de las funciones de la señalización PKA es la regulación del citoesqueleto, por eso, estudiamos las funciones celulares que podrían verse afectadas por este. Observamos que las células de ambos grupos de pacientes de BD mostraban menos puntos de adhesión al sustrato, que se restableció tras el tratamiento con litio, mientras las células de pacientes LNR mostraron un aumento del tamaño celular que no fueron restauradas por el litio. Observamos también una disminución en la migración celular tanto en pacientes LNR y LR respecto al control que no fue restaurada por el litio. Realizamos también un análisis ROC de varias proteínas que destacaron como marcadores significativamente discriminantes de la respuesta al litio. Además, de las 48 proteínas que cambiaron su expresión al comparar las células de LR o LNR con las de control, sólo una de ellas, la proteína TK2, se restauró sólo en LR tras el tratamiento con litio (AUC: 93,8%; Pvalue: 0,006). In vivo, las células progenitoras derivadas de neuroepitelio olfativo tras cuatro semanas de implantación sobreviven, estas células no presentan marcadores gliales (GFAP), sin embargo, hay un alto porcentaje de células Neun+ en el hipocampo de ratones nude adultos. Estos resultados indicarían que las células humanas ONE son capaces de integrarse en el circuito neuronal de un ratón nude y diferenciarse hacía neuronas maduras. Sin embargo, no se observaron diferencias significativas en la diferenciación neuronal entre los diferentes grupos experimentales (ratones con células injertadas de controles, pacientes LR y LNR). Aunque si se tiene en cuenta la distribución de las células progenitoras humanas derivadas del neuroepitelio olfativo en las diferentes áreas del hipocampo podemos observar un aumento de células humanas que coexpresan NeuN solo en los pacientes LNR respecto a los LR. Los resultados de esta tesis permitirán comprender mejor las bases biológicas del consumo de cannabis y del BD, identificar nuevos biomarcadores que indiquen qué pacientes tienen más probabilidades de responder adecuadamente al tratamiento con litio, y allanar el camino para el desarrollo de nuevas terapias farmacológicas., In mental illness, the search for biomarkers has been slowed down by the impossibility of obtaining neural samples from living patients. The olfactory neuroepithelium ("Olfactory NEuroepithelium", ONE) is a peripheral nervous tissue that represents an interesting surrogate model to study the effects of drugs on the brain, as well as the etiopathogenesis of the disease itself, since it is closely related to the central nervous system. In the present thesis we use human ONE-derived cells as a tool to search for biological risk factors in mental disorders, specifically risk factors enhanced by cannabis use and risk and response factors to pharmacological treatment in bipolar disorder I (BDI). Cannabis is the third most commonly used psychoactive substance, but it also receives considerable attention as a potential therapeutic drug. BD is a highly heritable psychiatric illness, with a lifetime prevalence of 1-3%. The first-line treatment is lithium which achieves a satisfactory response in monotherapy of approximately 30%. The lack of neurobiological understanding of these pathologies prevents the improvement of current treatments and the discovery of new therapeutic targets. In this thesis we use ONE cells from chronic cannabis users and healthy control subjects to evaluate alterations in relevant cellular processes, and identify changes in functional proteomic pathways due to cannabis use. Following a similar strategy, we seek biomarkers that can help predict clinical response to lithium in patients with BD who respond (lithium responder, LR) or do not respond (lithium non responder, LNR) to lithium, and discover new therapeutic targets. In addition, we will study the neural differentiation potential of olfactory neuroepithelium-derived cells in vivo. ONE cells from cannabis users showed alterations in the expression of proteins related to the cytoskeleton, cell proliferation and cell death. Our results indicate that cannabis may alter key processes in the developing brain, some of which are similar to those reported in mental disorders such as schizophrenia and bipolar disorder. Further studies showed that cannabis caused increased cell size and morphological alterations evident through β-Tubulin III staining, as well as increased expression of β-actin and decreased focal adhesion, suggesting abnormalities of the cytoskeleton and cell adhesion system. On the other hand, proteomic analysis performed on both BD patient-derived cells and blood samples (Peripheral Blood Mononuclear Cell, PBMCs) extracted from patients showed that the PKA signaling pathway was down-regulated in LR patientderived ONE cells compared to healthy control cells, but was up-regulated in LNR. In vitro treatment with lithium restored the PKA pathway, but exclusively in LR patients. One of the functions of PKA signaling is the regulation of the cytoskeleton, so we studied the cellular functions that could be affected by it. We observed that cells from both groups of BD patients showed fewer substrate adhesion points, which was restored after lithium treatment, while cells from LNR patients showed an increase in cell size that was not restored by lithium. We also observed a decrease in cell migration in both LNR and LR patients with respect to the control that was not restored by lithium. We also performed ROC analysis of several proteins that stood out as significant discriminating markers of lithium response. Furthermore, of the 48 proteins that changed their expression when comparing LR or LNR cells with control cells, only one of them, the TK2 protein, was restored only in LR after lithium treatment (AUC: 93.8%; Pvalue: 0.006). In vivo, olfactory neuroepithelium-derived progenitor cells after four weeks of implantation survive, these cells do not present glial markers (GFAP, IBA1), however, there is a high percentage of Neun+ cells in the hippocampus of adult nude mice. These results would indicate that human ONE cells are able to integrate into the neuronal circuitry of a nude mouse and differentiate into mature neurons. However, no significant differences in neuronal differentiation were observed between the different experimental groups (mice with grafted cells from controls, LR and LNR patients). Although taking into account the distribution of MITs in the different areas of the hippocampus we observed an increase of MIT cells coexpressing NeuN only in LNR patients with respect to LR patients. The results of this thesis will allow us to better understand the biological basis of cannabis use and BD, to identify new biomarkers that indicate which patients are more likely to respond adequately to lithium treatment, and to pave the way for the development of new pharmacological therapies., 192 páginas
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Pain in Neuropsychiatry: Insights From Animal Models

  • Bravo García, Lidia
  • Llorca Torralba, Meritxell
  • Suárez-Pereira, Irene
  • Berrocoso Domínguez, Esther María
Pain is the most common symptom reported in clinical practice, meaning that it is associated with many pathologies as either the origin or a consequence of other illnesses. Furthermore, pain is a complex emotional and sensorial experience, as the correspondence between pain and body damage varies considerably. While these issues are widely acknowledged in clinical pain research, until recently they have not been extensively considered when exploring animal models, important tools for understanding pain pathophysiology. Interestingly, chronic pain is currently considered a risk factor to suffer psychiatric disorders, mainly stress-related disorders like anxiety and depression. Conversely, pain appears to be altered in many psychiatric disorders, such as depression, anxiety and schizophrenia. Thus, pain and psychiatric disorders have been linked in epidemiological and clinical terms, although the neurobiological mechanisms involved in this pathological bidirectional relationship remain unclear. Here we review the evidence obtained from animal models about the co-morbidity of pain and psychiatric disorders, placing special emphasis on the different dimensions of pain.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Unraveling the potential of hypothalamic deep brain stimulation for obesity: Impacts on memory, neuroplasticity and brain metabolism in the Zucker rat

  • Casquero-Veiga, Marta
  • Llorca Torralba, Meritxell
  • Bueno-Fernandez, C.
  • Romero-Miguel, Diego
  • Lamanna-Rama, Nicolás
  • Winter, C.
  • Berrocoso Domínguez, Esther María
  • Nacher, Juan
  • Desco, Manuel
  • Soto-Montenegro, María Luisa
The lateral hypothalamus (LH) plays a key role in regulating energy balance and appetite, making it a potential target for deep brain stimulation (DBS) in treatment-resistant obesity. In this study, we evaluated the short and long-term in vivo effects of continuous LH-DBS over 15 days in a genetic model of obesity: the Zucker rat. We examined changes in body weight, brain glucose metabolism (via positron emission tomography, PET), and memory performance, along with ex vivo neuroplasticity in different hippocampal layers one month post-treatment. Contrary to expectations, continuous LH-DBS did not reduce the weight gain or food intake. While stimulated rats exhibited hippocampal hypermetabolism and enhanced synaptogenesis, these changes did not translate into cognitive improvements. Interestingly, long-term memory benefits were observed in all animals that underwent surgery, regardless of whether they received stimulation. In conclusion, our results do not support continuous LH-DBS as an effective treatment to reduce body weight in cases of obesity with genetic leptin resistance. However, the hippocampal modulation induced by continuous LH-DBS shows potential for addressing cognitive impairments associated with leptin resistance. These findings suggest that alternative DBS protocols may help restore hippocampal function, warranting further investigation.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Distinct patterns of cell adhesion, migration, and morphology in olfactory neuroepithelium cells of bipolar disorder patients

  • Delgado Sequera, Alejandra Cristina
  • Pérez Revuelta, José Ildefonso
  • Caballero-García, Andrés
  • Durán Ruiz, María del Carmen
  • Romero López Alberca, Cristina
  • Garcia-Mompo, Clara
  • González Saiz, Francisco Manuel
  • Rodríguez Iglesias, Manuel Antonio
  • Sánchez Morillo, Daniel
  • Robledo, Patricia
  • Pérez, Víctor
  • Berrocoso Domínguez, Esther María
  • Hidalgo Figueroa, María
Background Bipolar disorder (BD) is a severe, chronic mental illness that remains difficult to diagnose due to the lack of specific biomarkers, relying primarily on clinical assessments. Early diagnosis and treatment are essential for improving prognosis and lowering suicide risk. This study aimed to identify biomarkers and therapeutic targets by utilizing olfactory neuroepithelium (ONE) cells from patients with BD and controls. Methods Immunofluorescence of ONE cells, along with proteomic and RNA sequencing analyses, was performed to investigate cytoskeletal changes and pathways involved in cell adhesion, movement, and morphology. Additionally, potential biomarkers were investigated in blood samples to improve clinical accessibility. Results Thus, according to functional assays, ONE cells derived from BD patients exhibited decreased substrate adhesion, reduced cell migration, and morphological changes compared to control cells. In addition, proteomic and RNAseq analyses in ONE cells and peripheral blood mononuclear cells (PBMCs) revealed alterations in pathways such as RhoA/PAK/Integrin and Actin Cytoskeleton Signaling, as well as significant changes in inflammatory and immunological pathways. AUROC analysis identified proteins like PTK2 as potential diagnostic biomarkers, showing altered expression in both ONE cells and PBMCs. PTK2 RNA expression correlated with distinct morphological traits in BD ONE cells. Conclusions In summary, this study identified cytoskeletal alterations, reduced adhesion, and disrupted migration patterns in BD ONE cells, highlighting molecular mechanisms underlying these changes and emphasizing PTK2’s role as a potential diagnostic biomarker for BD., Funding for open access publishing: Universidad de Cádiz/CBUA. This study was supported by the 2014–2020 FEDER Operational Programme and by the Department of Economy, Knowledge, Business and University of the Regional Government of Andalusia (FEDER-UCA18-106933). This work was also supported by the “Programa Operativo de Andalucía FEDER, Iniciativa Territorial Integrada ITI 2014–2020″ Conserjería de Salud—Junta de Andalucía” (PI-0009–2017); by the “Conserjería de Salud y Familias—Junta de Andalucía” (PEMP-0008–2020); Conserjería de Salud y Consumo—Junta de Andalucía (PI-0114-2024); the “Consejería de Economía, Innovación, Ciencia y Empleo de la Junta de Andalucía” (CTS-510); the “Centro de Investigación Biomédica en Red de Salud Mental-CIBERSAM” (CB/07/09/0033; CB/07/09/0029) and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación de España.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

A Systematic Review of the Molecular and Cellular Alterations Induced by Cannabis That May Serve as Risk Factors for Bipolar Disorder

  • Delgado Sequera, Alejandra Cristina
  • Garcia-Mompo, Clara
  • González-Pinto, Ana
  • Hidalgo Figueroa, María
  • Berrocoso Domínguez, Esther María
Background: Cannabis use is a risk factor of psychiatric illness, such as bipolar disorder type-I (BDI). Indeed, cannabis use strongly influences the onset and clinical course of BDI, although the biological mechanisms underlying this interaction remain unknown. Therefore, we have reviewed the biological mechanisms affected by cannabis use that may trigger BD. Methods: A systematic review was carried out of articles in which gene expression was studied in cannabis users or human-derived cells exposed to tetrahydrocannabinol (THC) or cannabidiol (CBD). A second systematic review was then performed to identify articles in which gene expression was studied in BDI samples, highlighting those that described alterations to the same molecular and cellular mechanisms affected by cannabis/THC/CBD. Results: The initial search identified 82 studies on cannabis and 962 on BDI. After removing duplicates and applying the inclusion/ exclusion criteria, 9 studies into cannabis and 228 on BDI were retained. The molecular and cellular mechanisms altered by cannabis use or THC/CBD exposure were then identified, including neural development and function, cytoskeletal function, cell adhesion, mitochondrial biology, inflammatory related pathways, lipid metabolism, the endocannabinoid system, the hypocretin/orexin system, and apoptosis. Alterations to those activities were also described in 19 of 228 focused on BDI. Conclusions: The biological mechanisms described in this study may be good candidates to the search for diagnostic biomarkers and therapeutic targets for BDI. Because cannabis use can trigger the onset of BD, further studies would be of interest to determine whether they are involved in the early development of the disorder, prompting early treatment.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

A Characterization of the Effects of Minocycline Treatment During Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders

  • Romero-Miguel, Diego
  • Casquero-Veiga, Marta
  • MacDowell, Karina S.
  • Torres Sánchez, Sonia
  • García Partida, José Antonio
  • Lamanna-Rama, Nicolás
  • Romero-Miranda, Ana
  • Berrocoso Domínguez, Esther María
  • Leza, Juan Carlos
  • Desco, Manuel
  • Soto-Montenegro, María Luisa
Background: Minocycline (MIN) is a tetracycline with antioxidant, anti-inflammatory, and neuroprotective properties. Given the likely involvement of inflammation and oxidative stress (IOS) in schizophrenia, MIN has been proposed as a potential adjuvant treatment in this pathology. We tested an early therapeutic window, during adolescence, as prevention of the schizophrenia-related deficits in the maternal immune stimulation (MIS) animal model. Methods: On gestational day 15, Poly I:C or vehicle was injected in pregnant Wistar rats. A total 93 male offspring received MIN (30 mg/kg) or saline from postnatal day (PND) 35-49. At PND70, rats were submitted to the prepulse inhibition test. FDG-PET and T2-weighted MRI brain studies were performed at adulthood. IOS markers were evaluated in frozen brain tissue. Results: MIN treatment did not prevent prepulse inhibition test behavioral deficits in MIS offspring. However, MIN prevented morphometric abnormalities in the third ventricle but not in the hippocampus. Additionally, MIN reduced brain metabolism in cerebellum and increased it in nucleus accumbens. Finally, MIN reduced the expression of iNOS (prefrontal cortex, caudate-putamen) and increased the levels of KEAP1 (prefrontal cortex), HO1 and NQO1 (amygdala, hippocampus), and HO1 (caudate-putamen). Conclusions: MIN treatment during adolescence partially counteracts volumetric abnormalities and IOS deficits in the MIS model, likely via iNOS and Nrf2-ARE pathways, also increasing the expression of cytoprotective enzymes. However, MIN treatment during this peripubertal stage does not prevent sensorimotor gating deficits. Therefore, even though it does not prevent all the MIS-derived abnormalities evaluated, our results suggest the potential utility of early treatment with MIN in other schizophrenia domains., M.L.S. was supported by the Ministerio de Ciencia, Innovacion y Universidades, Instituto de Salud Carlos III (projects PI14/00860 and PI17/01766, and grant CPII14/00005), co-financed by European Regional Development Fund (ERDF), "A way of making Europe", CIBER of Mental Health (CIBERSAM), Delegacion del Gobierno para el Plan Nacional sobre Drogas (2017/085), Fundacion Mapfre and Fundacion Alicia Koplowitz. M.C.-V. was supported by Fundacion Tatiana Perez de Guzman el Bueno. D.R.-M. was supported by Consejeria de Educacion e Investigacion, Comunidad de Madrid, co-funded by European Social Fund "Investing in your future" (grant, PEJD-2018-PRE/BMD-7899). N.L.-R. was supported by Instituto de investigacion Sanitaria Gregorio Maranon. A.R.-M. was supported by Consejeria de Educacion e Investigacion, Comunidad de Madrid, co-funded by European Social Fund "Investing in your future" (grant, PEJ15/BIO/TL-0216). The CNIC was supported by the Spanish Ministerio de Ciencia, Innovacion y Universidades (MCIU) and the Pro-CNIC Foundation. J.C.L. was supported by the Spanish Ministry of Economy, Industry and Competitiveness (MINECOEU-FEDER) SAF2016-75500-R and CIBERSAM. E.B.D., S.T.-S., and J.A.G.-P. were supported by grants: co-financed by the "Fondo Europeo de Desarrollo Regional" (FEDER)-UE "A way to build Europe" from the "Ministerio de Economia y Competitividad" (MINECO: RTI2018-099778-B-I00) and the "Ministerio de SaludInstituto de Salud Carlos III (PI18/01691); from the "Plan Nacional sobre Drogas, Ministerio de Sanidad, Consumo y Bienestar Social" (2019I041); from the "Programa Operativo de Andalucia FEDER, Iniciativa Territorial Integrada ITI 2014-2020 Consejeria Salud, Junta de Andalucia" (PI-0080-2017 and PI-0009-2017); from the Consejeria de Salud de la Junta de Andalucia (PI-0134-2018); from the University of Cadiz (PR2019-046); from the "Instituto de Investigacion e Innovacion en Ciencias Biomedicas de Cadiz-INiBICA" (IN-C22; LI19/06IN-CO22); from the "Consejeria de Economia, Innovacion, Ciencia y Empleo de la Junta de Andalucia" (CTS-510); from the "CIBERSAM" (CB/07/09/0033).
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

The effects of mango leaf extract during adolescence and adulthood in a rat model of schizophrenia

  • García Partida, José Antonio
  • Torres Sánchez, Sonia
  • MacDowell, Karina S.
  • Fernández Ponce, María Teresa
  • Casas Cardoso, Lourdes
  • Mantell Serrano, Casimiro
  • Soto-Montenegro, María Luisa
  • Romero-Miguel, Diego
  • Lamanna-Rama, Nicolás
  • Leza, Juan Carlos
  • Desco, Manuel
  • Berrocoso Domínguez, Esther María
There is evidence that in schizophrenia, imbalances in inflammatory and oxidative processes occur during pregnancy and in the early postnatal period, generating interest in the potential therapeutic efficacy of anti-inflammatory and antioxidant compounds. Mangiferin is a polyphenolic compound abundant in the leaves of Mangifera indica L. that has robust antioxidant and anti-inflammatory properties, making it a potential candidate for preventive or co-adjuvant therapy in schizophrenia. Hence, this study set-out to evaluate the effect of mango leaf extract (MLE) in a model of schizophrenia based on maternal immune activation, in which Poly I:C (4 mg/kg) is administered intravenously to pregnant rats. Young adult (postnatal day 60-70) or adolescent (postnatal day 35-49) male offspring received MLE (50 mg/kg of mangiferin) daily, and the effects of MLE in adolescence were compared to those of risperidone, assessing behavior, brain magnetic resonance imaging (MRI), and oxidative/inflammatory and antioxidant mediators in the adult offspring. MLE treatment in adulthood reversed the deficit in prepulse inhibition (PPI) but it failed to attenuate the sensitivity to amphetamine and the deficit in novel object recognition (NOR) induced. By contrast, adolescent MLE treatment prevented the sensorimotor gating deficit in the PPI test, producing an effect similar to that of risperidone. This MLE treatment also produced a reduction in grooming behavior, but it had no effect on anxiety or novel object recognition memory. MRI studies revealed that adolescent MLE administration partially counteracted the cortical shrinkage, and cerebellum and ventricle enlargement. In addition, MLE administration in adolescence reduced iNOS mediated inflammatory activation and it promoted the expression of biomarkers of compensatory antioxidant activity in the prefrontal cortex and hippocampus, as witnessed through the reduction of Keap1 and the accumulation of NRF2 and HO1. Together, these findings suggest that MLE might be an alternative therapeutic or preventive add-on strategy to improve the clinical expression of schizophrenia in adulthood, while also modifying the time course of this disease at earlier stages in populations at high-risk.